About the Author
Dr. Wallace Bridge is the scientist behind Glyteine® — the world's only clinically proven ingredient capable of rapidly increasing cellular glutathione levels in a single dose. In 1997, while serving as Program Leader at the CRC for Food Industry Innovation at UNSW, Dr. Bridge identified the extraordinary therapeutic potential of gamma-glutamylcysteine (GGC), the body's immediate precursor to glutathione. After finding it was not commercially available, he and his PhD student Dr. Martin Zarka spent over two decades developing and patenting a proprietary manufacturing process — ultimately creating the ingredient now branded as Glyteine®.
With over 35 years in biotechnology and bioprocessing — spanning CSIRO, CSR Ltd, Burns Philp, and nearly 20 years on faculty at UNSW — Dr. Bridge brings rare depth to both the science and commercialisation of Glyteine®. As Honorary Associate Professor at UNSW, he continues active research in cellular glutathione replenishment, cancer immunology, and therapeutic applications of GGC. His work has been recognised by Johnson & Johnson Innovation's QuickFire Challenge on Immune Support, and underpins every product in the Continual-G® range.
Areas of Expertise
Credentials & Experience
-
Honorary Associate Professor — University of New South Wales (UNSW)Sydney, Australia · Oct 2020–Present2020–Now
-
Director, Biotechnology Program & Associate Professor — UNSW BABSSchool of Biotechnology and Biomolecular Sciences, Faculty of Science · Research: Cancer immunology & GGC / cellular glutathione replenishment2008–2020
-
Director, Entrepreneurs in Science Unit — Faculty of Science, UNSWFounding Program Authority: Diploma in Innovation Management (3451/2461) and Graduate Certificate in Research Management and Commercialisation (7330)2001–2008
-
Program Leader: Biofractionation & Commercialisation Manager — UNSW / CRC for Food Industry InnovationDevelopment of fermentation processes for medium-to-high value food ingredients · IP commercialisation management1998–2000
-
Program Leader, Biofractionation — Burns Philp & Co Ltd / CRC for Food Industry Innovation, UNSWDevelopment of value-add products from baker's yeast — foundational research leading to the discovery of Glyteine®1994–1997
-
Senior Scientist — Roferm SpA, Rovereto, ItalyPilot and industrial-scale optimisation of manufacturing processes for Cephalosporin C (Ceph C) and 7-ACA1992–1994
-
Earlier Research Roles — CSIRO & CSR Ltd, AustraliaCSIRO Division of Food Research (1986–1988) · CSR Ltd Central Laboratories, Pyrmont, Sydney (1984–1986)1984–1992
Education
Doctor of Philosophy (PhD)
Biotechnology · UNSW
1989 – 1992Master of Applied Science
Biotechnology · UNSW
1987 – 1989Bachelor of Science
Genetics & Microbiology · University of Sydney
1980 – 1983Editorial Policy
Science-Backed. Fact-Checked. Transparent.
All content authored by Dr. Wallace Bridge is grounded in peer-reviewed science and based on his 25+ years of direct research into cellular glutathione and GGC biochemistry. Articles are reviewed for accuracy before publication and updated when new research emerges. Dr. Bridge discloses his affiliation with INID Research Lab and Continual-G® on all authored content.
